Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis

Affiliations

• ¹ Division of Rheumatology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada; Department of Medicine, Université de Montréal, Montreal, QC, Canada; Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada. Electronic address: sabrina.hoa@mail.mcgill.ca.
• ² Department of Medicine, McGill University, Montreal, QC, Canada; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
• ³ Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada; Department of Medicine, McGill University, Montreal, QC, Canada; Division of Rheumatology, Jewish General Hospital, Montreal, QC, Canada.
• ⁴ Rheumatology Unit, Royal Adelaide Hospital, Adelaide, SA, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
• ⁵ Department of Rheumatology, St. Vincent's Hospital (Melbourne), Fitzroy, VIC, Australia.
• ⁶ Department of Rheumatology, Monash Health, Clayton, VIC, Australia.
• ⁷ Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.
• ⁸ Department of Mathematics and Statistics, McGill University, Montreal, QC, Canada.
• ⁹ Department of Rheumatology, St. Vincent's Hospital (Melbourne), Fitzroy, VIC, Australia; Department of Medicine, University of Melbourne at St. Vincent's Hospital (Melbourne), Fitzroy, VIC, Australia.